• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury, as assessed for causality using the updated RUCAM.

广告
作者单位: Hepatology and Liver Transplantation Unit, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France. [1] Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier University Hospital, Montpellier, France. [2] Department of Medical Oncology, Montpellier Cancer Institute, Montpellier University Hospital, Montpellier, France.;Internal Medicine, Beziers Hospital, Béziers, France. [3] Hepatology and Liver Transplantation Unit, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France.;Department of Oncology, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France. [4] Hepatology and Liver Transplantation Unit, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France.;REFHEPS, Montpellier, France. [5] Department of Dermatology, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France. [6] Internal Medicine & Immuno-Oncology (MedI2O), Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France. [7] Department of Oncology, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France. [8] Hepatology and Liver Transplantation Unit, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France.;Department of Oncology, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France.;Montpellier University, Montpellier, France. [9] Department of Pathology, Montpellier University Hospital, University of Montpellier, Montpellier, France. [10] Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier University Hospital, Montpellier, France.;Montpellier University, Montpellier, France. [11] Department of Medical Oncology, Montpellier Cancer Institute, Montpellier University Hospital, Montpellier, France. [12] Hepatology and Liver Transplantation Unit, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France.;Montpellier University, Montpellier, France. [13] Internal Medicine & Immuno-Oncology (MedI2O), Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France.;Montpellier University, Montpellier, France.;Internal Medicine & Immuno-Oncology (MedI2O), Institute for Regenerative Medicine and Biotherapy (IRMB), Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France. [14] Hepatology and Liver Transplantation Unit, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France.;REFHEPS, Montpellier, France.;Internal Medicine & Immuno-Oncology (MedI2O), Institute for Regenerative Medicine and Biotherapy (IRMB), Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France. [15]
DOI 10.1111/apt.18276
PMID 39315730
发布时间 2024-12-05
提交
  • 浏览0
Alimentary pharmacology & therapeutics

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷